Tradewind BioScience
Tradewind translates scientific insight into innovative ways of…
What they do
Ovarian cancer patients need more effective treatments that can both directly attack tumors and activate the immune system against cancer.
The company develops a multifaceted therapeutic antibody designed to target primary ovarian cancer cells while enabling the immune system's natural anti-cancer response.
Oncologists and hospitals treating ovarian cancer patients, via pharmaceutical development and clinical use.
Founders
As a full-time founder at Tradewind, my focus is on translating novel science into viable and novel therapeutic approaches and relating the value of our mission. This calls on skills and knowledge developed through 25 years of cancer research experience and more recent experience in business oriented rolls. Skills/Experience - PhD level cancer biologist - Management of a research team - Patent portfolio management and IP agreements - Scientific data analysis and interpretation
Company timeline
- Founded2017
- YC batchWinter 2018
- StatusActive
- Team size2 people
- LocationSan Francisco, CA, USA
Similar startups
